Vaccine Adjuvants Market

Vaccine Adjuvants Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: Apr 2026 | Format: | No. of Pages: 192

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Sample / Information

The vaccine adjuvants industry is estimated to be valued at USD 2.6 Billion in 2026.

North America is projected to account for the largest market share in 2025.

The industry is estimated to rise at a CAGR of 6% from 2026 to 2033.

Pfizer Inc., GlaxoSmithKline plc, and AstraZeneca are few of the key contributors.

Rising prevalence of influenza and government investments in healthcare are key enablers.

Quality assured

Confidentiality assured

Custom research services